sábado, 16 de abril de 2022

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases - The Lancet Rheumatology

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario